Nguyen, A. T. (2026 Supplement 19). Real-world outcomes of first-line afatinib in advanced non–small cell lung cancer patients with uncommon EGFR mutations at Vietnam National Cancer Hospital. Journal of Clinical Oncology, 44, 277-304.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Nguyen, Anh Tuan. "Real-world Outcomes of First-line Afatinib in Advanced Non–small Cell Lung Cancer Patients with Uncommon EGFR Mutations at Vietnam National Cancer Hospital."
Journal of Clinical Oncology 44 (2026 Supplement 19): 277-304.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Nguyen, Anh Tuan. "Real-world Outcomes of First-line Afatinib in Advanced Non–small Cell Lung Cancer Patients with Uncommon EGFR Mutations at Vietnam National Cancer Hospital."
Journal of Clinical Oncology, vol. 44, 2026 Supplement 19, pp. 277-304.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.